ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Insights into the prognosis of lipidomic dysregulation for death risk in patients with coronary artery disease

Qin, Min; Zhu, Qian; Lai, Weihua; Ma, Qilin; Liu, Chen; Chen, Xiaoping; Zhang, Yuelin; Wang, Zixian; Chen, Hui; Yan, Hong; Lei, Heping; Zhang, Shuyao; Dong, Xuekui; Wang, Hong; Huang, Min; Lian, Qizhou; Zhong, Shilong*广东省人民医院; 中山大学; 1
Clinical and Translational Medicine2020-9DOI: 10.1002/ctm2.189
15被引7阅读
引用收藏
分享

摘要

Background Dyslipidaemia contributes to the progression of coronary artery disease (CAD) toward adverse outcomes. Plasma lipidomic measure may improve the prognostic performances of clinical endpoints of CAD. Our research is designed to identify the correlations between plasma lipid species and the risks of death, major adverse cardiovascular event (MACE) and left ventricular (LV) remodeling in patients with CAD. Methods A total of 1569 Chinese patients with CAD, 1011 single-centre patients as internal training cohort, and 558 multicentre patients as external validation cohort, were enrolled. The concentration of plasma lipids in both cohorts was determined through widely targeted lipidomic profiling. Least absolute shrinkage and selection operator Cox and multivariate Cox regressions were used to develop prognostic models for death and MACE, respectively. Results Ten (Cer(d18:1/20:1), Cer(d18:1/24:1), PE(30:2), PE(32:0), PE(32:2), PC(O-38:2), PC(O-36:4), PC(16:1/22:2), LPC(18:2/0:0) and LPE(0:0/24:6)) and two (Cer(d18:1/20:1) and LPC(20:0/0:0)) lipid species were independently related to death and MACE, respectively. Cer(d18:1/20:1) and Cer(d18:1/24:1) were correlated with LV remodeling (P < .05). The lipidic panel incorporating 10 lipid species and two traditional biomarkers for predicting 5-year death risk represented a remarkable higher discrimination than traditional model with increased area under the curve from 76.56 to 83.65%, continuous NRI of 0.634 and IDI of 0.131. Furthermore, the panel was successfully used in differentiating multicentre patients with low, middle, or high risks (P < .0001). Further analysis indicated that the number of double bonds of phosphatidyl choline and the content of carbon atoms of phosphatidyl ethanolamines were negatively associated with death risk. Conclusions Improvement in the prediction of death confirms the effectiveness of plasma lipids as predictors to risk classification in patients with CAD. The association between the structural characteristics of long-chain polyunsaturated fatty acids and death risk highlights the need for mechanistic research that characterizes the role of individual lipid species in disease pathogenesis.

学科与关键词

关键词
coronary artery diseasedeathleft ventricular remodelinglong-chain polyunsaturated fatty acidsrisk stratificationwidely targeted lipidomic profiling
相关
加载中…
  • Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease
    Zhu, Qian; Qin, Min; Wang, Zixian; Wu, Yonglin; Chen, Xiaoping; Liu, Chen; Ma, Qilin; Liu, Yibin; Lai, Weihua; Chen, Hui; Cai, Jingjing; Liu, Yemao; Lei, Fang; Zhang, Bin; Zhang, Shuyao; He, Guodong; Li, Hanping; Zhang, Mingliang; Zheng, Hui; Chen, Jiyan; Huang, Min; Zhong, Shilong*Cell and Bioscience, 2022, 12(1): 173.被引 3
  • Comprehensive Metabolomics Identified the Prominent Role of Glycerophospholipid Metabolism in Coronary Artery Disease Progression
    Chen, Hui; Wang, Zixian; Qin, Min; Zhang, Bin; Lin, Lu; Ma, Qilin; Liu, Chen; Chen, Xiaoping; Li, Hanping; Lai, Weihua; Zhong, Shilong*Frontiers in Molecular Biosciences, 2021, 8: 632950.被引 14
  • Coronary Artery Disease: Optimal Lipoprotein(a) for Survival-Lower Is Better? A Large Cohort With 43,647 Patients
    Liu, Jin; Liu, Liwei; Wang, Bo; Chen, Shiqun; Liu, Buyun; Liang, Jingjing; Huang, Haozhang; Li, Qiang; Lun, Zhubin; Ying, Ming; Chen, Guanzhong; Huang, Zhidong; Xu, Danyuan; Yan, Xiaoming; Zhu, Tingting; Tadesse, Girmaw Abebe; Tan, Ning; Chen, Jiyan; Liu, Yong*Frontiers in Cardiovascular Medicine, 2021, 8: 670859.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Clinical and Translational Medicine
发表日期
2020-09
卷期
第 10 卷, 第 5 期
页码
e189
DOI
10.1002/ctm2.189
期刊收录
NSL.SCIE
期刊等级
2区
成果收录
SCIE
资助标注
Guangdong key areas R&D projects, China [2019B020229003]; Science and Technology Development Projects of Guangdong Province, China [2017B0303314041]; National Natural Science Foundation of China [81872934, 81673514]

作者

  • Q

    Qin, Min (第一作者)

    guangdong prov peoples hosp

  • Z

    Zhu, Qian

    guangdong prov peoples hosp

查看全部 17 位作者收起作者
  • L

    Lai, Weihua

    guangdong prov peoples hosp

  • M

    Ma, Qilin

  • L

    Liu, Chen

    1 · sun yat sen univ

  • C

    Chen, Xiaoping

  • Z

    Zhang, Yuelin

    guangdong prov peoples hosp

  • W

    Wang, Zixian

    guangdong prov peoples hosp

  • C

    Chen, Hui

    guangdong prov peoples hosp

  • Y

    Yan, Hong

    guangdong prov peoples hosp

  • L

    Lei, Heping

    guangdong prov peoples hosp

  • Z

    Zhang, Shuyao

  • D

    Dong, Xuekui

  • W

    Wang, Hong

  • H

    Huang, Min

    sun yat sen univ

  • L

    Lian, Qizhou

    univ hong kong

  • Z

    Zhong, Shilong (通讯)

    guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417